While there is no definitive cure for COVID-19 yet, scientists are leaving no stone unturned in the hopes of being able to formulate a possible treatment for the coronavirus. Recently, scientists saw that the antibodies present in llamas may be able to help in fighting the coronavirus.
COVID-19 is still affecting millions of people all over the world, with hundreds of thousands of people dying from the disease. Scientists from University of California, San Francisco are looking to harness the antibodies present among llamas to be able to formulate a cure or vaccine for the coronavirus. To do this, they created a molecule inspired by these antibodies and they found that it was actually very effective at inhibiting the coronavirus.
According to molecular biologist and biochemist Peter Walter, who is among the scientists who are working on the possible COVID-19 treatment from llama antibodies, “It binds the virus’ spike protein with unmatched affinity -- we’ve never seen anything like this in my lab before. It was absolutely beautiful to see.”
Despite the promising result, more tests and studies are needed to be done before it can really prove to be a cure for COVID-19. Nevertheless, this study suggests how far scientists are going to be able to come up with ways to combat the coronavirus.
So far, other drugs are used to treat the symptoms of COVID-19, and previously, the Food and Drug Administration of the US announced that the use of the drug remdesivir is now allowed for COVID-19 patients who are hospitalized. The agency issued a press release informing of their decision to give remdesivir to COVID-19 patients the green light.
“The FDA continues to make safe and potentially helpful treatments for COVID-19 available as quickly as possible in order to help patients. The data to support today’s action are encouraging. The data show that this treatment has the potential to help even more patients who are suffering from the effects of this devastating virus. We are working with drug developers to conduct randomized clinical trials to further study the safety and effectiveness of a number of potential therapies for COVID-19,” said FDA Commissioner Stephen Hahn.


UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
Trump Signs Order to Cut Routine Childhood Vaccines
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
RFK Jr. Orders Extended Hantavirus Quarantine for Cruise Passenger
3 clinical-grade skincare creams you really shouldn’t buy online
NASA Resumes Cygnus XL Cargo Docking with Space Station After Software Fix
Trump Administration Bars U.S. Travelers From Congo Flights Amid Ebola Outbreak
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss 



